beta-lapachone has been researched along with MELAS in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Excerpt | Relevance | Reference |
---|---|---|
"Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a mitochondrial disease caused by mutations in the mitochondrial genome." | 3.80 | β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells. ( Jeong, MH; Kim, JH; Kwak, TH; Park, WJ; Seo, KS, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeong, MH | 1 |
Kim, JH | 1 |
Seo, KS | 1 |
Kwak, TH | 1 |
Park, WJ | 1 |
1 other study available for beta-lapachone and MELAS
Article | Year |
---|---|
β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells.
Topics: DNA, Mitochondrial; Energy Metabolism; Gene Expression Regulation; HeLa Cells; Humans; Lactic Acid; | 2014 |